降低STMN2和致病性TDP-43,两种ALS的标志,协同加速小鼠的运动衰退
Kelsey L Krus1, Ana Morales Benitez1, Amy Strickland2
1Department of Developmental Biology, Washington University School of Medicine, St. Louis, United States, 63110.
bioRxiv : the preprint server for biology
|April 2, 2024
概括
降低的Stathmin2 (STMN2) 功能加剧了TDP-43蛋白病变,导致小鼠的渐进式运动缺陷. 这突出了STMN2恢复作为潜在的治疗策略神经退行性疾病,如ALS.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- TDP-43病理学是肌缩侧面硬化症 (ALS) 和前性痴呆症的核心.
- 在主要的神经退行性疾病中观察到Stathmin2 (STMN2) mRNA的异常拼接.
- 在体内,STMN2的枯竭部分模仿了类似于ALS的症状.
研究的目的:
- 在小鼠模型中研究减少STMN2功能和TDP-43突变的协同效应.
- 探索针对TDP-43蛋白病变中STMN2的潜在治疗策略.
主要方法:
- 产生了一个非功能性Stmn2副本和一个突变的TDP-43Q331K等位基因的跨异质合体小鼠.
- 评估了受影响小鼠的行为表型,神经病理学和线粒体形态学.
主要成果:
- 协同作用的相互作用导致了早期发作的,渐进的运动缺陷.
- 在中枢或外围神经系统中没有发现显著的神经病理.
- 在远端轴突和神经肌肉结 (NMJs) 中观察到异常的线粒体形态.
结论:
- 部分STMN2损失显著加剧了TDP-43相关的表型.
- 距离轴突和NMJ的线粒体功能障碍可能是运动缺陷的基础.
- 恢复STMN2可能为TDP-43蛋白质病变提供治疗途径.
更多相关视频
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
19.3K
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
2.6K
相关概念视频
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
